TNFRSF14 and breast cancer: TNFRSF14 (HVEM) has been observed to have a prognostic impact in breast cancer depending on the level of tumor-infiltrating lymphocytes (TILs), and the worst outcome occurs in patients with high TNFRSF14 expression and low TIL tumors [38].